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The Capacity to Vote of Persons With Alzheimer’s Disease
Abstract
OBJECTIVE: The right to vote can be abrogated when persons become incompetent to cast a ballot. This
applies particularly to people with Alzheimer’s disease, who at some point will lose capacity. A 2001
federal court decision offered the first clear criteria (“Doe voting capacity standard”) for determining
voting competence, focused on understanding the nature and effect of voting and on the ability to
choose. This article explores how persons with Alzheimer’s disease perform on these criteria.
METHOD: The Doe standard was operationalized in a brief questionnaire, along with measures of
appreciation and reasoning about voting choices. Performance was assessed in 33 patients attending an
Alzheimer’s disease clinic and was related to dementia severity and demographic characteristics.
RESULTS: The interview questions were scored with high reliability. Performance on the Doe questions,
along with appreciation and reasoning, correlated strongly with Mini-Mental State Examination (MMSE)
scores. Patients with very mild to mild Alzheimer’s disease generally retained adequate ability to vote, and
most persons with severe Alzheimer’s disease did not. Performance was highly variable among persons
with moderate Alzheimer’s disease. The desire to vote was a poor predictor of voting capacity.
CONCLUSIONS: The capacity to vote, as embodied in the Doe voting capacity standard, can be measured
simply and reliably. Structured assessment is particularly likely to be useful for people with moderate
Alzheimer’s disease, whose performance cannot be predicted from MMSE scores alone. This approach
can ensure retention of voting rights by capable persons and exclusion of clearly impaired persons from
the voting booth.

Disciplines
Bioethics and Medical Ethics | Neuroscience and Neurobiology | Neurosciences

Comments
Postprint version.

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/neuroethics_pubs/17

